Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of Von Willebrand's disease. Blood. 1987;69:454–9.
CAS
PubMed
Google Scholar
Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of Von Willebrand disease. Thromb Haemost. 2000;84:160–74.
CAS
PubMed
Google Scholar
James PD, Lillicrap D. Von Willebrand disease: clinical and laboratory lessons learned from the large Von Willebrand disease studies. Am J Hematol. 2012;87 Suppl 1:S4–11.
Article
PubMed
PubMed Central
Google Scholar
Favaloro EJ. Diagnosis and classification of Von Willebrand disease: a review of the differential utility of various functional Von Willebrand factor assays. Blood Coagul Fibrinolysis. 2011;22:553–64.
Article
CAS
PubMed
Google Scholar
Ahmad F, Oyen F, Jan R, Budde U, Schneppenheim R, Saxena R. Germline de novo mutations and linkage markers vs. DNA sequencing for carrier detection in Von Willebrand disease. Haemophilia. 2014;20:e311–7.
Article
CAS
PubMed
Google Scholar
Taylor SA, Deugau KV, Lillicrap DP. Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency). Proc Natl Acad Sci U S A. 1991;88:39–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Update on the pathophysiology and classification of Von Willebrand disease: a report of the subcommittee on Von Willebrand Factor. J Thromb Haemost. 2006;4:2103–14.
Article
CAS
PubMed
Google Scholar
Federici AB. Clinical and laboratory diagnosis of VWD. Hematology; Am Soc Hematol, Educ Program. 2014;2014:524–30.
Google Scholar
Sié P, Caron C, Azam J, Goudemand J, Grandjean H, Boneu B, et al. Reassessment of Von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1 and 2 during normal pregnancy. Br J Haematol. 2003;121:897–903.
Article
PubMed
Google Scholar
Chen D, Tange JI, Meyers BJ, Pruthi RK, Nichols WL, Heit JA. Validation of an automated latex particle-enhanced immunoturbidimetric Von Willebrand factor activity assay. J Thromb Haemost. 2011;9:1993–2002.
Article
CAS
PubMed
Google Scholar
Lasne D, Dey C, Dautzenberg MD, Cherqaoui Z, Monge F, Aouba A, et al. Screening for Von Willebrand disease: contribution of an automated assay for Von Willebrand factor activity. Haemophilia. 2012;18:e158–63.
Article
CAS
PubMed
Google Scholar
Shen MC, Lin JS, Lin DS, Hsu SC, Lin B. A first Taiwanese Chinese family of type 2B Von Willebrand disease with R1306W mutation. Thromb Res. 2003;112:291–5.
Article
CAS
PubMed
Google Scholar
Kuo SJ, Ma GC, Chang SP, Wu HH, Chen CP, Chang TM, et al. Preimplantation and prenatal genetic diagnosis of aromatic L-amino acid decarboxylase deficiency with an amplification refractory mutation system-quantitative polymerase chain reaction. Taiwan J Obstet Gynecol. 2011;50:468–73.
Article
PubMed
Google Scholar
Chen HF, Chang SP, Wu SH, Lin WH, Lee YC, Ni YH, et al. Validating a rapid, real-time, PCR-based direct mutation detection assay for preimplantation genetic diagnosis. Gene. 2014;548:299–305.
Article
CAS
PubMed
Google Scholar
Schneppenheim R, Budde U, Obser T, Brassard J, Mainusch K, Ruggeri ZM, et al. Expression and characterization of Von Willebrand factor dimerization defects in different types of Von Willebrand disease. Blood. 2001;97:2059–66.
Article
CAS
PubMed
Google Scholar
James PD, Notley C, Hegadorn C, Leggo J, Tuttle A, Tinlin S, et al. The mutational spectrum of type 1 Von Willebrand disease: Results from a Canadian cohort study. Blood. 2007;109:145–54.
Article
CAS
PubMed
Google Scholar
Goodeve A, Castaman G, Rodeghiero F, Federici AB, Batlle J, Meyer D. Rate of de novo VWF mutations in patients historically diagnosed with type 1 VWD in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). J Thromb Haemost. 2007;5 Suppl 2:P-T-189.
Google Scholar
James PD, Goodeve AC. Von Willebrand disease. Genet Med. 2011;13:365–76.
Article
CAS
PubMed
Google Scholar
Murray EW, Giles AR, Lillicrap D. Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of Von Willebrand factor, causing type IIB Von Willebrand disease. Am J Hum Genet. 1992;50:199–207.
CAS
PubMed
PubMed Central
Google Scholar
Flood VH. New insights into genotype and phenotype of VWD. Hematology Am Soc Hematol Educ Program. 2014;2014:531–35.
PubMed
PubMed Central
Google Scholar
Depienne C, Trouillard O, Gourfinkel-An I, Saint-Martin C, Bouteiller D, Graber D, et al. Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet. 2010;47:404–10.